Catalyst Wire Dossier Catalyst Wire Dossier

Thyronajod Mite Tablets (50 μg levothyroxine / 75 μg iodine)

Levothyroxine/Iodine combination
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Thyronajod Mite Tablets (50 μg levothyroxine / 75 μg iodine), covering 2011-11-07 to 2011-11-07. Get the full timeline:

Most recent: Clinical Trial Update: Bioavailability Investigations of Thyronajod Mite Tablets of Dosage Strengths 50 μg Levothyrox-ine/75 μg Iodine, and 100 μg Levothyroxine/75 μg Iodine vs. a Levothyroxine Drinking-Solution: A Randomised Cross Over Study in Healthy Male Individuals. Currently: 50 μg/ 75 μg Tablets [Phase 1]

See pricing